# Fund for Ophthalmic Knowledge Inc

Grantmaking public charity, New York, New York. EIN 13-4171637.

Source: the foundation’s own IRS returns, read November 20, 2026, as shown by the Alleviate Index. https://transform.alleviate.org/index/funder/fund-for-ophthalmic-knowledge-inc-134171637

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Fund for Ophthalmic Knowledge Inc accepts applications.

## What it gave

- Grants paid: $129,934 (Year ending December 2024)
- Grants listed: 1 (To organizations, on that return)
- Typical grant: $56,128 (The median of the grants listed)

- December 2024: Grants paid $129,934; Grants listed 1
- December 2023: Grants paid $247,857; Grants listed 1

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

## What it funds, and where

- Focus, by share of linked grant dollars: None of its grants could be linked to a charity with certainty, so no focus is shown.
- Where it gave, by number of grants: New York 2

## Recent grants to organizations

- MEMORIAL SLOAN KETTERING CANCER CENTER (New York, New York): $56,128, year ending December 2024. SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
- MEMORIAL SLOAN KETTERING CANCER CENTER (New York, New York): $198,692, year ending December 2023. SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.

Method and sources: https://transform.alleviate.org/index/method#funders
